PIA
AMPH icon

Piedmont Investment Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Piedmont Investment Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,358
Closed -$128K – 1094
2018
Q2 		$128K Buy
+8,358
New +$146K 0.01% 1021

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Piedmont Investment Advisors's AMPH Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2018, closing a stake of 8,358 shares — an estimated $128K sold.

Piedmont Investment Advisors first reported a position in AMPH in Q2 2018 and held it in 1 quarter. The position peaked at $128K in Q2 2018. 108 funds tracked by Wall St. Rank hold AMPH as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Amphastar Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 8,358 Amphastar Pharmaceuticals shares in Q3 2018, an estimated $128K.
  • Piedmont Investment Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Amphastar Pharmaceuticals position peaked at $128K in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.